Inactive Instrument

Phoenix Life Sciences International Limited Share Price Other OTC

Equities

PLSI

US71910Q1022

Pharmaceuticals

Dynamic Chart
ArCare Holdings Sdn Bhd entered into letter of intent to acquire Phoenix Life Sciences International Limited. CI
Phoenix Life Sciences International Limited cancelled the transaction announced on April 30, 2019 CI
Phoenix Life Sciences International Limited Reports Earnings Results for the Full Year Ended February 28, 2019 CI
Phoenix Life Sciences International Limited Announces Management Changes CI
Phoenix Life Sciences International Limited Announces Resignation of Michael Gobel from His Role as Director CI
Phoenix Life Sciences International Limited Announces Management Changes CI
Phoenix Life Sciences International Limited Announces Management Changes CI
Phoenix Life Sciences International Limited Signs Exclusive Agreement with Vanuatu Government for 25-Year Diabetes Management Program and Global Medical Cannabis Export License CI
Phoenix Life Sciences International Limited Names Maturine Carlot-Tary as Director of Health and Nutrition CI
Phoenix Life Sciences International Limited announced that it expects to receive $40 million in funding CI
Phoenix Life Sciences International Limited Appoints John Taleo as Global Head of Security CI
Phoenix Life Sciences International Limited announced that it has received $0.879685 million in funding CI
Phoenix Life Sciences International Limited Appoints Tekon Timothy Tumukon as Head of Biosecurity Services CI
Phoenix Life Sciences International Limited Appoints Santus Wari as Head of National Healthcare of the Company CI
Phoenix Life Sciences International Limited Breaks Ground for Network of Community Clinics and Dispensing Pharmacies for the Republic of Vanuatu CI
More news
Managers TitleAgeSince
Chief Executive Officer - -
Chairman 65 24/04/14
Chief Investment Officer - -
Members of the board TitleAgeSince
Chairman 65 24/04/14
Chief Executive Officer - -
More insiders
Phoenix Life Sciences International Limited is a healthcare solutions company. The Company provides a range of healthcare services to help governments implement diabetes solutions and national healthcare programs. It is primarily engaged in the provision of diabetes management as part of its healthcare services program and approved Phoenix Metabolic rollout. It operates an integrated group of companies for the fulfillment of government-sponsored healthcare service programs, plant-based pharmaceutical production and ongoing research programs. Its healthcare service programs are designed to provide solutions to manage diabetes and other non-communicable diseases (NCD). It partners and produces plant-based pharmaceuticals to treat diabetes, pain, cancer, autoimmune diseases and anxiety and other conditions. Its products include Phoenix Metabolic, Phoenix Auto, Phoenix Calm, Phoenix Daytime, Phoenix Mood, Phoenix Neuro, Phoenix Onco, Phoenix Pain, Phoenix Relax and Phoenix Sleep.
More about the company